{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:56:05Z","timestamp":1790708165479,"version":"4.1.0"},"reference-count":158,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","award":["G-83837286"],"award-info":[{"award-number":["G-83837286"]}],"id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), considered the most common type of dementia, is characterized by a progressive loss of memory, visuospatial, language and complex cognitive abilities. In addition, patients often show comorbid depression and aggressiveness. Aging is the major factor contributing to AD; however, the initial cause that triggers the disease is yet unknown. Scientific evidence demonstrates that AD, especially the late onset of AD, is not the result of a single event, but rather it appears because of a combination of risk elements with the lack of protective ones. A major risk factor underlying the disease is neuroinflammation, which can be activated by different situations, including chronic pathogenic infections, prolonged stress and metabolic syndrome. Consequently, many therapeutic strategies against AD have been designed to reduce neuro-inflammation, with very promising results improving cognitive function in preclinical models of the disease. The literature is massive; thus, in this review we will revise the translational evidence of these early strategies focusing in anti-diabetic and anti-inflammatory molecules and discuss their therapeutic application in humans. Furthermore, we review the preclinical and clinical data of nutraceutical application against AD symptoms. Finally, we introduce new players underlying neuroinflammation in AD: the activity of the endocannabinoid system and the intestinal microbiota as neuroprotectors. This review highlights the importance of a broad multimodal approach to treat successfully the neuroinflammation underlying AD.<\/jats:p>","DOI":"10.3390\/ijms21228751","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T10:46:26Z","timestamp":1605782786000},"page":"8751","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Can We Treat Neuroinflammation in Alzheimer\u2019s Disease?"],"prefix":"10.3390","volume":"21","author":[{"given":"Sandra","family":"S\u00e1nchez-Saras\u00faa","sequence":"first","affiliation":[{"name":"Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-2754","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Espinosa-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6372-2842","authenticated-orcid":false,"given":"Juan Carlos","family":"Ledesma","sequence":"additional","affiliation":[{"name":"Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2018). 2018 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 14, 367\u2013429.","DOI":"10.1016\/j.jalz.2018.02.001"},{"key":"ref_2","first-page":"1","article-title":"A Review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","year":"2012","journal-title":"Sci. World J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Szabo, L., Eckert, A., and Grimm, A. (2020). Insights into disease-associated tau impact on mitochondria. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176344"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.3233\/JAD-2012-129001","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1570159X18666200122122512","article-title":"Role of oxidative stress and metal toxicity in the progression of Alzheimer\u2019s disease","volume":"18","author":"Birla","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_10","first-page":"1","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"PubMed. Oxid. Med. Cell. Longev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-386986-9.00011-9","article-title":"Alzheimer\u2019s disease and amyloid: Culprit or coincidence?","volume":"102","author":"Skaper","year":"2012","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000245156","article-title":"Peripheral cytokines and chemokines in Alzheimer\u2019s disease","volume":"28","author":"Lee","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/NEN.0b013e318217a118","article-title":"Brain oligomeric \u03b2-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein\/tau transgenic mice","volume":"70","author":"Scotton","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100966","DOI":"10.1016\/j.arr.2019.100966","article-title":"Is Alzheimer\u2019s disease an inflammasomopathy?","volume":"56","author":"Pereira","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer\u2019s disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Neuroscience: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/med.21553","article-title":"Recent clinical trends in Toll-like receptor targeting therapeutics","volume":"39","author":"Anwar","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-319-89390-7_3","article-title":"Inflammasomes in CNS Diseases","volume":"108","author":"Albornoz","year":"2018","journal-title":"Experientia Supplementum"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","article-title":"Role of inflammatory molecules in the Alzheimer\u2019s disease progression and diagnosis","volume":"376","author":"Bagyinszky","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00207454.2013.831852","article-title":"Neuroinflammation in Alzheimer\u2019s disease: An understanding of physiology and pathology","volume":"124","author":"Obulesu","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tournier, B.B., Tsartsalis, S., Ceyz\u00e9riat, K., Valentina, G., and Millet, P. (2020). In vivo TSPO signal and neuroinflammation in Alzheimer\u2019s disease. Cells, 9.","DOI":"10.3390\/cells9091941"},{"key":"ref_24","first-page":"647","article-title":"Activation of microglial cells by \u03b2-amyloid protein and interferon-\u03b3","volume":"374","author":"Meda","year":"1995","journal-title":"Nat. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Perea, J.R., Bol\u00f3s, M., and Avila, J. (2020). Microglia in Alzheimer\u2019s disease in the context of Tau pathology. Biomolecules, 10.","DOI":"10.3390\/biom10101439"},{"key":"ref_26","first-page":"1","article-title":"Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice","volume":"11","author":"Bilan","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_27","first-page":"674","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2020.570711","article-title":"The Role of microglia and the Nlrp3 inflammasome in Alzheimer\u2019s disease","volume":"11","author":"Hanslik","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Feng, Y.-S., Tan, Z.-X., Wu, L.-Y., Dong, F., and Zhang, F. (2020). The involvement of NLRP3 inflammasome in the treatment of Alzheimer\u2019s disease. Ageing Res. Rev., 101192.","DOI":"10.1016\/j.arr.2020.101192"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnagi.2020.00056","article-title":"Steps towards developing effective treatments for neuropsychiatric disturbances in Alzheimer\u2019s disease: Insights from preclinical models, clinical data, and future directions","volume":"12","author":"Clement","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-160488","article-title":"Inflammation, antiinflammatory agents, and Alzheimer\u2019s disease: The last 22 years","volume":"54","author":"McGeer","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2002-4510","article-title":"From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer\u2019s disease: The role of NSAIDs and cyclooxygenase in \u03b2-amyloidosis and clinical dementia1","volume":"4","author":"Pasinetti","year":"2002","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0000000000009185","article-title":"Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","volume":"94","author":"Breitner","year":"2020","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial and its follow-up study","volume":"11","author":"Breitner","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1515\/revneuro-2013-0050","article-title":"Insulin resistance, neuroinflammation, and Alzheimer\u2019s disease","volume":"25","author":"Najem","year":"2014","journal-title":"Rev. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"ref_39","first-page":"1","article-title":"Mechanisms linking inflammation to insulin resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimers disease","volume":"9","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","article-title":"Intranasal insulin in Alzheimer\u2019s dementia or mild cognitive impairment: A systematic review","volume":"265","author":"Avgerinos","year":"2018","journal-title":"J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","article-title":"AMP-activated protein kinase: A potential player in Alzheimer\u2019s disease","volume":"118","author":"Salminen","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jcb.10135","article-title":"Role of mTOR in the degradation of IRS-1: Regulation of PP2A activity","volume":"85","author":"Hartley","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.isci.2018.06.006","article-title":"Serine phosphorylation by mTORC1 promotes IRS-1 degradation through SCF\u03b2-TRCP E3 ubiquitin ligase","volume":"5","author":"Yoneyama","year":"2018","journal-title":"iScience"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the insulin sensitizer metformin in Alzheimer disease","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/oby.2009.266","article-title":"Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects","volume":"18","author":"Ricart","year":"2010","journal-title":"Obesity"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5604\/17322693.1021110","article-title":"A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids","volume":"66","author":"Artym","year":"2012","journal-title":"Post\u0119p. Higien. Med. Do\u015bw."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4081\/vl.2012.e6","article-title":"Ulcerated hemosiderinic dyschromia and iron deposits within lower limbs treated with a topical application of biological chelator","volume":"1","author":"Brizzio","year":"2012","journal-title":"Veins Lymphat."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopha.2018.12.118","article-title":"A pilot study on the effect of lactoferrin on Alzheimer\u2019s disease pathological sequelae: Impact of the p-Akt\/PTEN pathway","volume":"111","author":"Mohamed","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MCO.0b013e32833dfaec","article-title":"Vitamin B12: The forgotten micronutrient for critical care","volume":"13","author":"Manzanares","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-019-02053-1","article-title":"Vitamin B12 insufficiency is associated with increased risk of gestational diabetes mellitus: A systematic review and meta-analysis","volume":"66","author":"Kouroglou","year":"2019","journal-title":"Endocrine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.clnu.2017.07.008","article-title":"Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity","volume":"37","author":"Li","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/1567205016666190725144629","article-title":"Effects of folic acid and vitamin B12, alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: A single-blind experimental design","volume":"16","author":"Ma","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000486597","article-title":"Vitamin B12 in association with antipsychotic drugs can modulate the expression of pro-\/anti-inflammatory cytokines in Alzheimer disease patients","volume":"24","author":"Vakilian","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lfs.2017.04.024","article-title":"Evaluation of the effects of anti-psychotic drugs on the expression of CD68 on the peripheral blood monocytes of Alzheimer patients with psychotic symptoms","volume":"179","author":"Bahramabadi","year":"2017","journal-title":"Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14833","DOI":"10.1073\/pnas.93.25.14833","article-title":"Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein","volume":"93","author":"Ramprasad","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","first-page":"85","article-title":"Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients","volume":"32","author":"Farah","year":"2013","journal-title":"PubMed. Int. Angiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0026-0495(97)90298-5","article-title":"Insulin sensitivity, glucose effectiveness, and \u03b2-cell function in obese males with essential hypertension: Investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril)","volume":"46","author":"Iglesias","year":"1997","journal-title":"Metabolism"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases","volume":"230","author":"Wang","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lawlor, B.A., Segurado, R., Kennelly, S., Rikkert, M.G.M.O., Howard, R., Pasquier, F., B\u00f6rjesson-Hanson, A., Tsolaki, M., Lucca, U., and Molloy, D.W. (2018). Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002660"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biopha.2017.05.060","article-title":"Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer\u2019s disease via modulating the expression of miR-106b","volume":"92","author":"Huang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1871527315999160111160143","article-title":"Atorvastatin may correct dyslipidemia in adult patients at risk for Alzheimer\u2019s disease through an anti-inflammatory pathway","volume":"15","author":"Zhao","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","article-title":"Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial","volume":"84","author":"Elsen","year":"2015","journal-title":"Neurology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"66680","DOI":"10.18632\/oncotarget.19164","article-title":"Nanoformulations of curcumin: An emerging paradigm for improved remedial application","volume":"8","author":"Gera","year":"2017","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuroscience.2019.09.032","article-title":"Curcumin-loaded nanocapsules reverses the depressant-like behavior and oxidative stress induced by \u03b2-amyloid in mice","volume":"423","author":"Fidelis","year":"2019","journal-title":"Neuroscience"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nbd.2019.02.015","article-title":"Curcumin restores innate immune Alzheimer\u2019s disease risk gene expression to ameliorate Alzheimer pathogenesis","volume":"127","author":"Teter","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopha.2016.05.037","article-title":"Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial","volume":"82","author":"Panahi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Brown","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bbadis.2014.09.011","article-title":"Neuroprotective action of resveratrol","volume":"1852","author":"Bastianetto","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease","volume":"14","author":"Moussa","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3945\/jn.109.109785","article-title":"Green tea (-)-epigallocatechin-3-gallate inhibits \u03b2-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-\u03baB pathways in mice","volume":"139","author":"Lee","year":"2009","journal-title":"J. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-017-0145-6","article-title":"The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer\u2019s disease: An overview of pre-clinical studies and translational perspectives in clinical practice","volume":"12","author":"Cascella","year":"2017","journal-title":"Infect. Agents Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Mori, T., Koyama, N., Guillot-Sestier, M.-V., Tan, J., and Town, T. (2013). Ferulic Acid Is a Nutraceutical \u03b2-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055774"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1074\/jbc.RA118.004280","article-title":"Combined treatment with the phenolics (\u2212)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice","volume":"294","author":"Mori","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2016.06.008","article-title":"Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice","volume":"629","author":"Jin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3945\/an.116.012948","article-title":"Flavones: Food sources, bioavailability, metabolism, and bioactivity","volume":"8","author":"Hostetler","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.3390\/molecules18089949","article-title":"Neuroprotective, anti-amyloidogenic and neurotrophic effects of Apigenin in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"key":"ref_85","first-page":"224","article-title":"Protective effects of Puerarin against A \u03b2 1-42-induced learning and memory impairments in mice","volume":"83","author":"Wu","year":"2017","journal-title":"Planta Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1142\/S0192415X19500757","article-title":"Puerariae radix prevents anxiety and cognitive deficits in mice under oligomeric A\u03b2-induced stress","volume":"47","author":"Huang","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3233\/JAD-180361","article-title":"Walnut supplementation in the diet reduces oxidative damage and improves antioxidant status in transgenic mouse model of Alzheimer\u2019s disease","volume":"64","author":"Pandareesh","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1567205043332144","article-title":"Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils","volume":"1","author":"Chauhan","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2019.00821","article-title":"Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer\u2019s disease","volume":"10","author":"Beggiato","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): A randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Im, D.-S. (2020). Pro-Resolving Effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng. Biomololecules, 10.","DOI":"10.3390\/biom10030444"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1749-8546-5-20","article-title":"Pharmacology of ginsenosides: A literature review","volume":"5","author":"Leung","year":"2010","journal-title":"Chin. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1179\/1476830512Y.0000000027","article-title":"Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer\u2019s disease","volume":"15","author":"Heo","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jnutbio.2015.01.012","article-title":"Lycopene abrogates A\u03b2 (1\u201342)-mediated neuroinflammatory cascade in an experimental model of Alzheimer\u2019s disease","volume":"26","author":"Sachdeva","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-2012-120634","article-title":"Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany","volume":"31","author":"Herbolsheimer","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Atkinson, F.S., Villar, A., Mul\u00e0, A., Zangara, A., Risco, E., Smidt, C.R., Hontecillas, R., Leber, A., and Bassaganya-Riera, J. (2019). Abscisic acid standardized fig (Ficus carica) extracts ameliorate postprandial glycemic and insulinemic responses in healthy adults. Nutrients, 11.","DOI":"10.3390\/nu11081757"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/092986710790226110","article-title":"Mechanisms of action and medicinal applications of abscisic acid","volume":"17","author":"Skoneczka","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12870-017-1048-9","article-title":"Sinapic acid or its derivatives interfere with abscisic acid homeostasis during Arabidopsis thaliana seed germination","volume":"17","author":"Bi","year":"2017","journal-title":"BMC Plant Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bcp.2011.06.042","article-title":"Occurrence, function and potential medicinal applications of the phytohormone abscisic acid in animals and humans","volume":"82","author":"Li","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12986-016-0137-3","article-title":"The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation","volume":"13","author":"Moustafa","year":"2016","journal-title":"Nutr. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12035-018-1091-z","article-title":"Abscisic acid supplementation rescues high fat diet-induced alterations in hippocampal inflammation and IRSs expression","volume":"56","author":"Atef","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"112106","DOI":"10.1016\/j.bbr.2019.112106","article-title":"Early intervention with ABA prevents neuroinflammation and memory impairment in a triple transgenic mice model of Alzheimer\u2019s disease","volume":"374","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zou, S., and Kumar, U. (2018). Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030833"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fphar.2017.00020","article-title":"In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer\u2019s disease","volume":"8","author":"Watt","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1139\/cjpp-2016-0346","article-title":"Cannabinoid signaling in health and disease","volume":"95","author":"Lu","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00213-015-3889-y","article-title":"Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia","volume":"232","author":"Ahmed","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnins.2017.00030","article-title":"Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target","volume":"11","author":"Cassano","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2016.00294","article-title":"Cannabinoid receptors in the central nervous system: Their signaling and roles in disease","volume":"10","author":"Kendall","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer\u2019s disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"1283","author":"Pazos","year":"2009","journal-title":"Brain Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14336\/AD.2015.0617","article-title":"Potential therapeutical contributions of the endocannabinoid system towards aging and Alzheimer\u2019s disease","volume":"6","author":"Bonnet","year":"2015","journal-title":"Aging Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 Cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0305-9","article-title":"Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells","volume":"12","author":"Pihlaja","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","article-title":"Cannabinoid effects on \u03b2 amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro","volume":"34","author":"Janefjord","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5Y APP + cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2020.00124","article-title":"From cannabis sativa to cannabidiol: Promising therapeutic candidate for the treatment of neurodegenerative diseases","volume":"11","author":"Cassano","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"109545","DOI":"10.1016\/j.cellsig.2020.109545","article-title":"Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer\u2019s disease?","volume":"70","author":"Thompson","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A., Gasbarrini, A., and Mele, M.C. (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","article-title":"The microbiome-gut-brain axis in health and disease","volume":"46","author":"Dinan","year":"2017","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4103\/0366-6999.190667","article-title":"Gut Microbiota-brain Axis","volume":"129","author":"Wang","year":"2016","journal-title":"Chin. Med. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_129","first-page":"203","article-title":"The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","article-title":"Gut microbiota and dysbiosis in Alzheimer\u2019s disease: Implications for pathogenesis and treatment","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"Collins","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chom.2015.04.011","article-title":"Control of brain development, function, and behavior by the microbiome","volume":"17","author":"Sampson","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Goyal, D., Ali, S.A., and Singh, R.K. (2020). Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer\u2019s disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 110112.","DOI":"10.1016\/j.pnpbp.2020.110112"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and Alzheimer\u2019s disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer\u2019s disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mib.2012.12.001","article-title":"Microbial amyloids-functions and interactions within the host","volume":"16","author":"Schwartz","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer\u2019s disease-A critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.csbj.2019.09.008","article-title":"Microbiota-gut-brain axis and toll-like receptors in Alzheimer\u2019s disease","volume":"17","author":"Lin","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s12035-017-0419-4","article-title":"RAGE-TLR crosstalk sustains chronic inflammation in neurodegeneration","volume":"55","author":"Brokos","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnagi.2019.00284","article-title":"Neuroinflammation and the gut microbiota: Possible alternative therapeutic targets to counteract Alzheimer\u2019s disease?","volume":"11","author":"Cerovic","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","article-title":"Gram-negative bacterial molecules associate with Alzheimer disease pathology","volume":"87","author":"Zhan","year":"2016","journal-title":"Neurology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01760-1","article-title":"Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice","volume":"17","author":"Shi","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_145","first-page":"1812","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"Pellegrini","year":"2015","journal-title":"Gut"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment","volume":"47","author":"Nagpal","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/jnnp-2012-304792","article-title":"\u00c1 Mediterranean diet improves cognition: The PREDIMED-NAVARRA randomised trial","volume":"84","author":"Clavero","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_148","unstructured":"(2020, November 17). Probiotics: What You Need To Know. National Center for Complementary and Integrative Health (NIH), Available online: https:\/\/www.nccih.nih.gov\/health\/probiotics-what-you-need-to-know#:~%20:%20text=Probiotics%20are%20live%20microorganisms%20that,dietary%20supplements%2C%20and%20beauty%20products."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02587-2","article-title":"Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels","volume":"7","author":"Bonfili","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13368-2","article-title":"Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3920\/BM2018.0170","article-title":"Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Benef. Microbes"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fnagi.2017.00403","article-title":"Prebiotic effect of Fructooligosaccharides from Morinda officinalis on Alzheimer\u2019s disease in rodent models by targeting the microbiota-gut-brain axis","volume":"9","author":"Chen","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1021\/acs.jafc.8b07313","article-title":"Fructooligosaccharides ameliorating cognitive deficits and neurodegeneration in APP\/PS1 transgenic mice through modulating gut microbiota","volume":"67","author":"Sun","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Hoffman, J.D., Yanckello, L.M., Chlipala, G., Hammond, T.C., McCulloch, S.D., Parikh, I., Sun, S., Morganti, J.M., Green, S., and Lin, A.-L. (2019). Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221828"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0525-3","article-title":"Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice","volume":"9","author":"Sun","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","article-title":"Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model","volume":"69","author":"Kim","year":"2020","journal-title":"Gut"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/1980-57642020dn14-030008","article-title":"Dietary interventions and cognition of Alzheimer\u2019s disease patients: A systematic review of randomized controlled trial","volume":"14","author":"Moreira","year":"2020","journal-title":"Dement. Neuropsychol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8751\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:31Z","timestamp":1760178871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":158,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21228751"],"URL":"https:\/\/doi.org\/10.3390\/ijms21228751","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}